Guardant Health, Inc (GH) insider trading
Every open-market stock purchase and sale by Guardant Health, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Chris Freeman (C-suite exec) and 9 others sold $30.7M in the last 90 days.
- Last insider buy: Kumud Kalia (C-suite exec), $78.5K, 4 months ago.
- Congress: Jonathan Jackson bought $15K to $50K, 3 weeks ago.
Last 12 months: insiders bought $78.5K (1 buy) and sold $169M (56 sales). Last close $166.66 on Oct 21, 2026.
Recent GH insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 21, 2026 | Roberto Mignone (Director) | Bought (not open market) | — |
| Oct 21, 2026 | Roberto Mignone (Director) | Bought (not open market) | — |
| Oct 17, 2026 | Medina Manuel Hidalgo (Director) | Bought (not open market) | — |
| Oct 17, 2026 | Medina Manuel Hidalgo (Director) | Bought (not open market) | — |
| Oct 16, 2026 | Musa Tariq (Director) | Sold | $19.2K |
| Oct 15, 2026 | Musa Tariq (Director) | Bought (not open market) | — |
| Oct 15, 2026 | Musa Tariq (Director) | Bought (not open market) | — |
| Oct 14, 2026 | Alex M Azar II (Director) | Sold | $11K |
| Oct 12, 2026 | Alex M Azar II (Director) | Bought (not open market) | — |
| Oct 12, 2026 | Alex M Azar II (Director) | Bought (not open market) | — |
| Oct 1, 2026 | AmirAli Talasaz (CEO) | Sold (not open market) | $3M |
| Oct 1, 2026 | Helmy Eltoukhy (CEO) | Sold (not open market) | $3M |
| Oct 1, 2026 | Darya Chudova (CTO) | Sold (not open market) | $755K |
| Oct 1, 2026 | Michael Brian Bell (CFO) | Sold (not open market) | $684K |
| Oct 1, 2026 | John G. Saia (C-suite exec) | Sold (not open market) | $648K |
| Oct 1, 2026 | Chris Freeman (C-suite exec) | Sold (not open market) | $549K |
| Oct 1, 2026 | Kumud Kalia (C-suite exec) | Sold (not open market) | $536K |
| Oct 1, 2026 | Terilyn J. Monroe (C-suite exec) | Sold (not open market) | $367K |
| Oct 1, 2026 | John G. Saia (C-suite exec) | Bought (not open market) | — |
| Oct 1, 2026 | John G. Saia (C-suite exec) | Bought (not open market) | — |
| Oct 1, 2026 | John G. Saia (C-suite exec) | Bought (not open market) | — |
| Oct 1, 2026 | Michael Brian Bell (CFO) | Bought (not open market) | — |
| Oct 1, 2026 | Michael Brian Bell (CFO) | Bought (not open market) | — |
| Oct 1, 2026 | Michael Brian Bell (CFO) | Bought (not open market) | — |
| Oct 1, 2026 | Terilyn J. Monroe (C-suite exec) | Bought (not open market) | — |
Who's trading GH
- Roberto Mignone, Director: other filings, last Oct 21, 2026
- Medina Manuel Hidalgo, Director: sold $936K (11 sales), last Oct 17, 2026
- Musa Tariq, Director: sold $422K (11 sales), last Oct 16, 2026
- Alex M Azar II, Director: sold $156K (2 sales), last Oct 14, 2026
- John G. Saia, C-suite exec: sold $4.2M (6 sales), last Oct 1, 2026
- Helmy Eltoukhy, CEO: sold $22M (9 sales), last Oct 1, 2026
- Chris Freeman, C-suite exec: sold $16.9M (16 sales), last Oct 1, 2026
- Michael Brian Bell, CFO: sold $8.8M (14 sales), last Oct 1, 2026
- Darya Chudova, CTO: sold $4.4M (4 sales), last Oct 1, 2026
- Terilyn J. Monroe, C-suite exec: sold $15.9M (19 sales), last Oct 1, 2026
- AmirAli Talasaz, CEO: sold $79M (25 sales), last Oct 1, 2026
- Kumud Kalia, C-suite exec: bought $78.5K (1 buy), sold $5.9M (8 sales), last Oct 1, 2026
- Jonathan Jackson, Representative: bought $15K (1 buy), last Sep 28, 2026
- Steve E. Krognes, Director: sold $2.4M (5 sales), last Sep 16, 2026
- Ian T Clark, Director: sold $6.1M (6 sales), last Aug 4, 2026
Get free alerts when an insider at Guardant Health, Inc files a new trade →